Mar 6, 2025 04:15PM
Jan 6, 2025 06:00AM
Mar 22, 2024 04:15PM
Jan 23, 2024 09:00AM
Jan 23, 2024 09:00AM
Nov 13, 2023 04:05PM
Oct 2, 2023 09:04AM Revelation Biosciences (REVB) Announces Appointment of Lakhmir Chawla, M.D. to Board of Directors
Oct 2, 2023 09:00AM
Aug 11, 2023 04:10PM
Jun 29, 2023 09:00AM
Jun 12, 2023 04:15PM
May 22, 2023 09:00AM
Mar 30, 2023 05:42PM
Mar 13, 2023 09:00AM Revelation Biosciences Inc. Appoints Dr. Julia Bohannon and Dr. Antonio Hernandez to Scientific Advisory Board
Feb 13, 2023 04:20PM
Feb 9, 2023 09:43AM
Feb 9, 2023 09:42AM
Feb 7, 2023 09:06AM
Feb 7, 2023 09:00AM
Jan 31, 2023 12:00PM
Jan 31, 2023 12:00PM Revelation Biosciences Inc. Announces 1-for-35 Reverse Stock Split effective February 1, 2023 and Results of Special Meeting of Stockholders
Jan 10, 2023 09:00AM
Nov 18, 2022 09:02AM
Nov 18, 2022 09:00AM
Nov 10, 2022 04:30PM
Oct 25, 2022 11:13AM
Oct 25, 2022 09:01AM
Oct 25, 2022 09:00AM Revelation Biosciences Inc. Announces Positive Results in Preclinical Model of Acute and Chronic Kidney Disease
Oct 6, 2022 07:04AM
Oct 6, 2022 07:00AM
Aug 15, 2022 05:30PM
Aug 15, 2022 05:30PM
Jul 29, 2022 11:45AM
Jul 29, 2022 11:45AM
Jul 26, 2022 08:15AM Revelation Biosciences (REVB) Prices 8.33M Share Offering at $0.60/sh
Jul 26, 2022 08:15AM
Jul 26, 2022 08:15AM
Jul 25, 2022 06:13AM
Jul 22, 2022 06:30PM
Jul 22, 2022 06:30PM
Jul 14, 2022 09:00AM
Jul 14, 2022 09:00AM Revelation Biosciences Inc. Completes Database Lock for its Phase 1b CLEAR Clinical Study of REVTx-99b for the Treatment of Allergic Rhinitis
Jul 14, 2022 09:00AM
Jun 13, 2022 09:00AM
Jun 13, 2022 09:00AM
May 23, 2022 09:00AM
May 23, 2022 09:00AM
May 16, 2022 04:01PM
May 16, 2022 04:01PM Revelation Biosciences Inc. Announces Financial Results for the Three Months Ended March 31, 2022 and Recent Corporate Progress
Mar 30, 2022 09:02AM

26,712 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All